Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-249 manufacturers

Filters

Filters

Filters , active

Country of origin : Japan
1 products found

pp-249

Solution for infusion

Dossier type
CTD
Dossier status
Under development
Country of origin
Japan
GMP approvals
Japan
Comments
Indication: Diffuse large B-cell lymphoma (relapsed/refractory DLBCL), mantle cell lymphoma / Clinical stage: Phase 2 (multiple ongoing studies; ORR 21.7% in r/rDLBCL, 41.7% in rituximab-negative patients) / Modality: Engineered toxin body (ETB) / Mechanism & Target: Anti-CD20 single-chain variable fragment genetically fused to Shiga-like Toxin A (SLT-A); CD20-targeted cell internalization / Route & form: Intravenous infusion / Differentiation: Novel direct cell-kill via ribosome inactivation; internalization of non-internalizing CD20 antigen
Manufacturer #39448
Major research-based pharmaceutical company with pipeline in oncology, immunology, and rare diseases. Develops innovative biologics including engineered toxin conjugates for hematological malignancies. Advances Phase 2 oncology programs through global clinical development and partnerships.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.